⚠️
od 10/2026 nowy program VHL – belzutifan
Terapie w programie lekowym:
Leki w katalogu chemioterapii:
Bleomycin Sulphate
Capecitabine
Carboplatin
Ciclosporinum
Cisplatinum
Cladribinum
Cyklophosphamidum
Cytarabinum
Dacarbazinum
Denosumab
Doxorubicinum
Epirubicinum
Etoposidum
Fludarabinum
Fluorouracilum
Gemcitabine
Ifosfamidum
Kabozantynib
Lanreotidum
Lanreotidum (2)
Methotrexatum
Mitotanum
Octreotidum
Paclitaxel
Sorafenib
Temozolomidum
Topotecanum Inj.
Vincristinum
Vinorelbinum
Badania kliniczne w Polsce - zobacz więcej w 🔍 wyszukiwarce
- adrenal cancer
- thyroid cancer
- » A Multicentre, Open-label Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
- » A Randomized Registry Trial of Adjuvant Mitotane vs. Mitotane With Cisplatin/Etoposide After Primary Surgical Resection of Localized Adrenocortical Carcinoma With High Risk of Recurrence (ADIUVO-2 Trial)